Related Experiment Videos
CPS49-induced neurotoxicity does not cause limb patterning anomalies in developing chicken embryos
Chris Mahony1, Scott McMenemy1, Alexandra J Rafipay1
1School of Medicine, Medical Sciences and Nutrition, Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK.
Journal of Anatomy
|October 13, 2017
Summary
Thalidomide analog CPS49 is neurotoxic but does not cause limb defects by damaging nerves. Nerve damage is not the primary cause of thalidomide-induced limb malformations.
Area of Science:
- Developmental biology
- Neuroscience
- Teratology
Background:
- Thalidomide caused severe limb defects via unknown mechanisms, with theories involving blood vessel formation.
- Thalidomide is neurotoxic, and survivors show altered nerve patterns, suggesting a role for neurotoxicity in birth defects.
Purpose of the Study:
- To investigate if thalidomide analog CPS49 is neurotoxic.
- To determine if CPS49-induced neurotoxicity impacts limb development.
- To clarify the role of neurotoxicity in thalidomide-related limb malformations.
Main Methods:
- Chicken embryos were exposed to CPS49 at different developmental stages.
- Neurotoxicity was assessed, and nerve development was inhibited using β-bungarotoxin.
- Limb development, including size and cartilage patterning, was analyzed.
Main Results:
- CPS49 demonstrated neurotoxicity, causing neuronal loss in late-developing chicken limbs.
- CPS49 exposure did not affect limb size in late-developing limbs but impacted area in early limb buds.
- Inhibition or ablation of nerves throughout limb development did not cause significant limb patterning defects.
Conclusions:
- While CPS49 is neurotoxic, its effects on nerve development do not explain the severe limb patterning defects observed.
- Late innervation of chicken limbs and the lack of patterning defects after nerve inhibition suggest neurotoxicity is not the primary cause of CPS49/thalidomide-induced limb malformations.